Predict your next investment

qbf.qic.com.au

See what CB Insights has to offer

Investments

21

Portfolio Exits

6

About Queensland BioCapital Funds

QBF was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. The Fund invests in listed or unlisted companies which are commercializing Australian discoveries in drugs, devices or diagnostics.

Queensland BioCapital Funds Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Queensland BioCapital Funds

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Queensland BioCapital Funds in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Queensland BioCapital Funds Investments

21 Investments

Queensland BioCapital Funds has made 21 investments. Their latest investment was in Gelesis as part of their Series A - II on May 5, 2011.

CBI Logo

Queensland BioCapital Funds Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/12/2011

Series A - II

Gelesis

$3.63M

No

4/29/2011

Seed VC

Verva Pharmaceuticals

$1.89M

Yes

1

10/26/2010

Series A

Hatchtech

$6.3M

Yes

1

1/20/2009

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2008

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/12/2011

4/29/2011

10/26/2010

1/20/2009

1/11/2008

Round

Series A - II

Seed VC

Series A

Series A

Series A

Company

Gelesis

Verva Pharmaceuticals

Hatchtech

Subscribe to see more

Subscribe to see more

Amount

$3.63M

$1.89M

$6.3M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

10

10

Queensland BioCapital Funds Portfolio Exits

6 Portfolio Exits

Queensland BioCapital Funds has 6 portfolio exits. Their latest portfolio exit was Gelesis on July 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/19/2021

Acq - Pending

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

7/19/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Acq - Pending

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Queensland BioCapital Funds Team

1 Team Member

Queensland BioCapital Funds has 1 team member, including current Chief Executive Officer, Cherrell Hirst.

Name

Work History

Title

Status

Cherrell Hirst

Chief Executive Officer

Current

Name

Cherrell Hirst

Work History

Title

Chief Executive Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.